Jpmorgan Chase & Co »

Carmell Therapeutics Corp - US shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $12 33 0.39
2024-06-30 $59 45 1.33
2024-03-31 $17 7 2.57
2023-12-31 $7 2 3.50
2023-09-30 $4 1 4.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Virtu Financial
Tower Research Capital
Morgan Stanley

View all funds holding Carmell Therapeutics Corp - US